Activin Induces x-Zone Apoptosis That Inhibits Luteinizing Hormone-Dependent Adrenocortical Tumor Formation in Inhibin-Deficient Mice

REFERENCES

• Beuschlein, F., C. Mutch, D. L. Bavers, Y. M. Ulrich-Lai, W. C. Engeland, C. Keegan, and G. D. Hammer. 2002. Steroidogenic factor-1 is essential for compensatory adrenal growth following unilateral adrenalectomy. Endocrinology 143: 3122–3135.
   PubMed Web of Science ®Google Scholar
• Billiar, R. B., M. G. Leavitt, P. Smith, E. D. Albrecht, and G. J. Pepe. 1999. Functional capacity of fetal zone cells of the baboon fetal adrenal gland: a major source of α-inhibin. Biol. Reprod. 61: 142–146.
   PubMedGoogle Scholar
• Chen, Y. G., H. M. Lui, S. L. Lin, J. M. Lee, and S. Y. Ying. 2002. Regulation of cell proliferation, apoptosis, and carcinogenesis by activin. Exp. Biol. Med. (Maywood) 227: 75–87.
   PubMedGoogle Scholar
• Cipriano, S. C., L. Chen, K. H. Burns, A. Koff, and M. M. Matzuk. 2001. Inhibin and p27 interact to regulate gonadal tumorigenesis. Mol. Endocrinol. 15: 985–996.
   PubMedGoogle Scholar
• Coerver, K. A., T. K. Woodruff, M. J. Finegold, J. Mather, A. Bradley, and M. M. Matzuk. 1996. Activin signaling through activin receptor type II causes the cachexia-like symptoms in inhibin-deficient mice. Mol. Endocrinol. 10: 534–543.
   PubMed Web of Science ®Google Scholar
• Deacon, C. F., W. Mosley, and I. C. Jones. 1986. The X zone of the mouse adrenal cortex of the Swiss albino strain. Gen. Comp. Endocrinol. 61: 87–99.
   PubMedGoogle Scholar
• Eggenschwiler, J., T. Ludwig, P. Fisher, P. A. Leighton, S. M. Tilghman, and A. Efstratiadis. 1997. Mouse mutant embryos overexpressing IGF-II exhibit phenotypic features of the Beckwith-Wiedemann and Simpson-Golabi-Behmel syndromes. Genes Dev. 11: 3128–3142.
   PubMed Web of Science ®Google Scholar
• Eppert, K., S. W. Scherer, H. Ozcelik, R. Pirone, P. Hoodless, H. Kim, L. C. Tsui, B. Bapat, S. Gallinger, I. L. Andrulis, G. H. Thomsen, J. L. Wrana, and L. Attisano. 1996. MADR2 maps to 18q21 and encodes a TGF-β-regulated MAD-related protein that is functionally mutated in colorectal carcinoma. Cell 86: 543–552.
   PubMed Web of Science ®Google Scholar
• Hirokawa, N., and H. Ishikawa. 1974. Electron microscopic observations on postnatal development of the X zone in mouse adrenal cortex. Z. Anat. Entwicklungsgesch. 144: 85–100.
   PubMedGoogle Scholar
• Holmes, P. V., and A. D. Dickson. 1971. X-zone degeneration in the adrenal glands of adult and immature female mice. J. Anat. 108: 159–168.
   PubMedGoogle Scholar
• Howard-Miller, E. 1928. A transitory zone in the adrenal cortex which shows age and sex relationships. Am. J. Anat. 40: 251–293.
   Google Scholar
• Hsu, S. Y., R. J. Lai, D. Nanuel, and A. J. Hsueh. 1995. Different 5′-flanking regions of the inhibin-α gene target transgenes to the gonad and adrenal in an age-dependent manner in transgenic mice. Endocrinology 136: 5577–5586.
   PubMedGoogle Scholar
• James, L. A., A. M. Kelsey, J. M. Birch, and J. M. Varley. 1999. Highly consistent genetic alterations in childhood adrenocortical tumours detected by comparative genomic hybridization. Br. J. Cancer 81: 300–304.
   PubMed Web of Science ®Google Scholar
• Kanamaru, C., H. Yasuda, and T. Fujita. 2002. Involvement of Smad proteins in TGF-β and activin A-induced apoptosis and growth inhibition of liver cells. Hepatol. Res. 23: 211–219.
   PubMedGoogle Scholar
• Kananen, K., M. Markkula, M. Mikola, E. M. Rainio, A. McNeilly, and I. Huhtaniemi. 1996. Gonadectomy permits adrenocortical tumorigenesis in mice transgenic for the mouse inhibin α-subunit promoter/simian virus 40 T-antigen fusion gene: evidence for negative autoregulation of the inhibin α-subunit gene. Mol. Endocrinol. 10: 1667–1677.
   PubMedGoogle Scholar
• Keeney, D. S., C. M. Jenkins, and M. R. Waterman. 1995. Developmentally regulated expression of adrenal 17α-hydroxylase cytochrome P450 in the mouse embryo. Endocrinology 136: 4872–4879.
   PubMed Web of Science ®Google Scholar
• Kero, J., M. Poutanen, F. P. Zhang, N. Rahman, A. M. McNicol, J. H. Nilson, R. A. Keri, and I. T. Huhtaniemi. 2000. Elevated luteinizing hormone induces expression of its receptor and promotes steroidogenesis in the adrenal cortex. J. Clin. Investig. 105: 633–641.
   PubMed Web of Science ®Google Scholar
• Kumar, T. R., G. Palapattu, P. Wang, T. K. Woodruff, I. Boime, M. C. Byrne, and M. M. Matzuk. 1999. Transgenic models to study gonadotropin function: the role of follicle-stimulating hormone in gonadal growth and tumorigenesis. Mol. Endocrinol. 13: 851–865.
   PubMed Web of Science ®Google Scholar
• Kumar, T. R., Y. Wang, and M. M. Matzuk. 1996. Gonadotropins are essential modifier factors for gonadal tumor development in inhibin-deficient mice. Endocrinology 137: 4210–4216.
   PubMedGoogle Scholar
• Lacroix, A., P. Hamet, and J. M. Boutin. 1999. Leuprolide acetate therapy in luteinizing hormone-dependent Cushing's syndrome. N. Engl. J. Med. 341: 1577–1581.
   PubMed Web of Science ®Google Scholar
• Lassus, H., R. Salovaara, L. A. Aaltonen, and R. Butzow. 2001. Allelic analysis of serous ovarian carcinoma reveals two putative tumor suppressor loci at 18q22-q23 distal to SMAD4, SMAD2, and DCC. Am. J. Pathol. 159: 35–42.
   PubMedGoogle Scholar
• Ling, N., S. Y. Ying, N. Ueno, S. Shimasaki, F. Esch, M. Hotta, and R. Guillemin. 1986. Pituitary FSH is released by a heterodimer of the β-subunits from the two forms of inhibin. Nature 321: 779–782.
   PubMed Web of Science ®Google Scholar
• Lipsett, M. B., R. Hertz, and G. T. Ross. 1963. Clinical and pathophysiologic aspects of adrenocortical carcinoma. Am. J. Med. 35: 374.
   PubMed Web of Science ®Google Scholar
• Malkin, D., F. P. Li, L. C. Strong, J. F. Fraumeni, Jr., C. E. Nelson, D. H. Kim, J. Kassel, M. A. Gryka, F. Z. Bischoff, and M. A. Tainsky. 1990. Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science 250: 1233–1238.
   PubMed Web of Science ®Google Scholar
• Massague, J. 1998. TGF-β signal transduction. Annu. Rev. Biochem. 67: 753–791.
   PubMed Web of Science ®Google Scholar
• Matzuk, M. M., M. J. Finegold, J. P. Mather, L. Krummen, H. Lu, and A. Bradley. 1994. Development of cancer cachexia-like syndrome and adrenal tumors in inhibin-deficient mice. Proc. Natl. Acad. Sci. USA 91: 8817–8821.
   PubMed Web of Science ®Google Scholar
• Matzuk, M. M., M. J. Finegold, J. G. Su, A. J. Hsueh, and A. Bradley. 1992. α-Inhibin is a tumour-suppressor gene with gonadal specificity in mice. Nature 360: 313–319.
   PubMed Web of Science ®Google Scholar
• Matzuk, M. M., T. R. Kumar, and A. Bradley. 1995. Different phenotypes for mice deficient in either activins or activin receptor type II. Nature 374: 356–360.
   PubMed Web of Science ®Google Scholar
• Matzuk, M. M., T. R. Kumar, A. Vassalli, J. R. Bickenbach, D. R. Roop, R. Jaenisch, and A. Bradley. 1995. Functional analysis of activins during mammalian development. Nature 374: 354–356.
   PubMed Web of Science ®Google Scholar
• Mesiano, S., and R. B. Jaffe. 1997. Developmental and functional biology of the primate fetal adrenal cortex. Endocr. Rev. 18: 378–403.
   PubMed Web of Science ®Google Scholar
• Muro-Cacho, C. A., K. Rosario-Ortiz, S. Livingston, and T. Munoz-Antonia. 2001. Defective transforming growth factor β signaling pathway in head and neck squamous cell carcinoma as evidenced by the lack of expression of activated Smad2. Clin. Cancer Res. 7: 1618–1626.
   PubMedGoogle Scholar
• Muscatelli, F., T. M. Strom, A. P. Walker, E. Zanaria, D. Récan, A. Meindl, B. Bardoni, S. Guioli, G. Zehetner, and W. Rabl. 1994. Mutations in the DAX-1 gene give rise to both X-linked adrenal hypoplasia congenita and hypogonadotropic hypogonadism. Nature 372: 672–676.
   PubMed Web of Science ®Google Scholar
• Nussdorfer, G. G. 1986. Cytophysiology of the adrenal cortex. Int. Rev. Cytol. 98: 1–405.
   PubMedGoogle Scholar
• Orozco-Florian, R., J. A. McBride, B. E. Favara, A. Steele, S. J. Brown, and P. Steele. 1991. Congenital hepatoblastoma and Beckwith-Wiedemann syndrome: a case study including DNA ploidy profiles of tumor and adrenal cytomegaly. Pediatr. Pathol. 11: 131–142.
   PubMedGoogle Scholar
• Pabon, J. E., X. Li, Z. M. Lei, J. S. Sanfilippo, M. A. Yussman, and C. V. Rao. 1996. Novel presence of luteinizing hormone/chorionic gonadotropin receptors in human adrenal glands. J. Clin. Endocrinol. Metab. 81: 2397–2400.
   PubMed Web of Science ®Google Scholar
• Ribeiro, R. C., E. L. Michalkiewicz, B. C. Figueiredo, L. DeLacerda, F. Sandrini, M. D. Pianovsky, G. Sampaio, and R. Sandrini. 2000. Adrenocortical tumors in children. Braz. J. Med. Biol. Res. 33: 1225–1234.
   PubMedGoogle Scholar
• Risma, K. A., C. M. Clay, T. M. Nett, T. Wagner, J. Yun, and J. H. Nilson. 1995. Targeted overexpression of luteinizing hormone in transgenic mice leads to infertility, polycystic ovaries, and ovarian tumors. Proc. Natl. Acad. Sci. USA 92: 1322–1326.
   PubMed Web of Science ®Google Scholar
• Roberts, V. J., and S. L. Barth. 1994. Expression of messenger ribonucleic acids encoding the inhibin/activin system during mid- and late-gestation rat embryogenesis. Endocrinology 134: 914–923.
   PubMed Web of Science ®Google Scholar
• Roberts, V. J., P. E. Sawchenko, and W. Vale. 1991. Expression of inhibin/activin subunit messenger ribonucleic acids during rat embryogenesis. Endocrinology 128: 3122–3129.
   PubMedGoogle Scholar
• Shire, J. G. 1976. Degeneration of the adrenal X-zone in Tfm mice with inherited insensitivity to androgens. J. Endocrinol. 71: 445–446.
   PubMedGoogle Scholar
• Shou, W., T. K. Woodruff, and M. M. Matzuk. 1997. Role of androgens in testicular tumor development in inhibin-deficient mice. Endocrinology 138: 5000–5005.
   PubMedGoogle Scholar
• Smith, C., and S. Mackay. 1991. Morphological development and fate of the mouse mesonephros. J. Anat. 174: 171–184.
   PubMed Web of Science ®Google Scholar
• Spencer, S. J., S. Mesiano, J. Y. Lee, and R. B. Jaffe. 1999. Proliferation and apoptosis in the human adrenal cortex during the fetal and perinatal periods: implications for growth and remodeling. J. Clin. Endocrinol. Metab 84: 1110–1115.
   PubMed Web of Science ®Google Scholar
• Spencer, S. J., J. Rabinovici, S. Mesiano, P. C. Goldsmith, and R. B. Jaffe. 1992. Activin and inhibin in the human adrenal gland: regulation and differential effects in fetal and adult cells. J. Clin. Investig. 90: 142–149.
   PubMed Web of Science ®Google Scholar
• Uchida, K., M. Nagatake, H. Osada, Y. Yatabe, M. Kondo, T. Mitsudomi, A. Masuda, and T. Takahashi. 1996. Somatic in vivo alterations of the JV18-1 gene at 18q21 in human lung cancers. Cancer Res. 56: 5583–5585.
   PubMedGoogle Scholar
• Vale, W., J. Rivier, J. Vaughan, R. McClintock, A. Corrigan, W. Woo, D. Karr, and J. Spiess. 1986. Purification and characterization of an FSH releasing protein from porcine ovarian follicular fluid. Nature 321: 776–779.
   PubMed Web of Science ®Google Scholar
• Wiedemann, H. R. 1964. Complexe malformatif familial avec hernie ombilicale et macroglossie—un syndrome nouveau? J. Genet. Hum. 13: 223–232.
   PubMedGoogle Scholar
• Woodruff, T., L. Krummen, S. Chen, R. Lyon, S. Hansen, G. DeGuzman, R. Covello, J. Mather, and P. Cossum. 1993. Pharmacokinetic profile of recombinant human (rh) inhibin A and activin A in the immature rat. II. Tissue distribution of [125I]rh-inhibin A and [125I]rh-activin A in immature female and male rats. Endocrinology 132: 725–734.
   PubMedGoogle Scholar
• Wooten, M. D., and D. K. King. 1993. Adrenal cortical carcinoma: epidemiology and treatment with mitotane and a review of the literature. Cancer 72: 3145–3155.
   PubMed Web of Science ®Google Scholar
• Yu, R. N., M. Ito, T. L. Saunders, S. A. Camper, and J. L. Jameson. 1998. Role of Ahch in gonadal development and gametogenesis. Nat. Genet. 20: 353–357.
   PubMed Web of Science ®Google Scholar